TAGGED AS: SDPA
-
Comorbidities in Psoriasis: Fact or Fiction?
-
Comorbidities in Psoriasis: Fact or Fiction?
-
What’s New in Cutaneous Infection?
-
What’s New in Cutaneous Infection?
-
SDPA Summer 2018 | Surgical Tips and Pearls with Jeff Johnson, PA-C
-
SDPA Summer 2018 | Surgical Tips and Pearls with Jeff Johnson, PA-C
-
Product Theater: TREMFYA: A Selective IL-23 Inhibitor With Pivotal Studies vs. Adalimumab
-
Product Theater: TREMFYA: A Selective IL-23 Inhibitor With Pivotal Studies vs. Adalimumab
-
Does Dupilumab Affect Vaccine Response?
-
Cues to Choose: How to Decide Which Psoriasis Therapy is Right for Special Populations
